Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks of cancer, including tumor proliferation, invasion and metastasis, inflammation, angiogenesis, and escape of immune survei...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbertz, Stephan, Sawyer, J Scott, Stauber, Anja J, Gueorguieva, Ivelina, Driscoll, Kyla E, Estrem, Shawn T, Cleverly, Ann L, Desaiah, Durisala, Guba, Susan C, Benhadji, Karim A, Slapak, Christopher A, Lahn, Michael M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539082/
https://www.ncbi.nlm.nih.gov/pubmed/26309397
http://dx.doi.org/10.2147/DDDT.S86621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539082/
https://www.ncbi.nlm.nih.gov/pubmed/26309397
http://dx.doi.org/10.2147/DDDT.S86621

Ejemplares similares